Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Deutsche Wohnen SE stock logo
DWHHF
Deutsche Wohnen
$19.46
$22.66
$19.46
$25.14
$7.79B0.637 shsN/A
Eurofins Scientific SE stock logo
ERFSF
Eurofins Scientific
$62.50
-3.5%
$62.22
$47.14
$72.39
$12.46B0.732,598 shs3,131 shs
Ferrovial SE stock logo
FRRVY
Ferrovial
$31.00
+1.2%
$31.00
$21.90
$33.57
$22.55B0.997,322 shs39,400 shs
Rakuten Group, Inc. stock logo
RKUNY
Rakuten Group
$4.95
+2.7%
$5.45
$3.22
$6.00
$10.33B0.9722,060 shs13,453 shs
Sino Biopharmaceutical Limited stock logo
SBMFF
Sino Biopharmaceutical
$0.31
$0.36
$0.32
$0.54
$5.92B0.45413 shsN/A
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Deutsche Wohnen SE stock logo
DWHHF
Deutsche Wohnen
0.00%0.00%-17.79%-17.79%-7.82%
Eurofins Scientific SE stock logo
ERFSF
Eurofins Scientific
-3.47%+0.26%+3.82%+2.15%-7.06%
Ferrovial SE stock logo
FRRVY
Ferrovial
0.00%0.00%0.00%0.00%+1.27%
Rakuten Group, Inc. stock logo
RKUNY
Rakuten Group
+2.70%-11.13%-13.45%+12.24%+0.20%
Sino Biopharmaceutical Limited stock logo
SBMFF
Sino Biopharmaceutical
+0.02%-17.71%-13.08%-24.22%-43.75%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Deutsche Wohnen SE stock logo
DWHHF
Deutsche Wohnen
N/AN/AN/AN/AN/AN/AN/AN/A
Eurofins Scientific SE stock logo
ERFSF
Eurofins Scientific
N/AN/AN/AN/AN/AN/AN/AN/A
Ferrovial SE stock logo
FRRVY
Ferrovial
N/AN/AN/AN/AN/AN/AN/AN/A
Rakuten Group, Inc. stock logo
RKUNY
Rakuten Group
N/AN/AN/AN/AN/AN/AN/AN/A
Sino Biopharmaceutical Limited stock logo
SBMFF
Sino Biopharmaceutical
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Deutsche Wohnen SE stock logo
DWHHF
Deutsche Wohnen
N/AN/AN/AN/A
Eurofins Scientific SE stock logo
ERFSF
Eurofins Scientific
2.00
HoldN/AN/A
Ferrovial SE stock logo
FRRVY
Ferrovial
3.00
BuyN/AN/A
Rakuten Group, Inc. stock logo
RKUNY
Rakuten Group
2.00
HoldN/AN/A
Sino Biopharmaceutical Limited stock logo
SBMFF
Sino Biopharmaceutical
N/AN/AN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Deutsche Wohnen SE stock logo
DWHHF
Deutsche Wohnen
$1.61B4.85N/AN/A$44.15 per share0.44
Eurofins Scientific SE stock logo
ERFSF
Eurofins Scientific
$7.05B1.71$6.30 per share9.92$26.56 per share2.35
Ferrovial SE stock logo
FRRVY
Ferrovial
$7.96B2.83$0.31 per share99.44$9.15 per share3.39
Rakuten Group, Inc. stock logo
RKUNY
Rakuten Group
$14.77B0.72N/AN/A$3.61 per share1.37
Sino Biopharmaceutical Limited stock logo
SBMFF
Sino Biopharmaceutical
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Deutsche Wohnen SE stock logo
DWHHF
Deutsche Wohnen
-$457.37MN/A0.00N/AN/AN/AN/AN/A
Eurofins Scientific SE stock logo
ERFSF
Eurofins Scientific
$335.48MN/A0.0017.56N/AN/AN/AN/AN/A
Ferrovial SE stock logo
FRRVY
Ferrovial
$187.57MN/A0.00N/AN/AN/AN/AN/A
Rakuten Group, Inc. stock logo
RKUNY
Rakuten Group
-$2.41B-$1.26N/A10.10N/A-16.31%-32.05%-1.54%N/A
Sino Biopharmaceutical Limited stock logo
SBMFF
Sino Biopharmaceutical
N/AN/A0.00N/AN/AN/AN/AN/A

Latest ERFSF, SBMFF, DWHHF, FRRVY, and RKUNY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
2/14/2024Q4 2023
Rakuten Group, Inc. stock logo
RKUNY
Rakuten Group
N/A-$0.43-$0.43-$0.43N/A$3.93 billion

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Deutsche Wohnen SE stock logo
DWHHF
Deutsche Wohnen
N/AN/AN/AN/AN/A
Eurofins Scientific SE stock logo
ERFSF
Eurofins Scientific
N/AN/AN/AN/AN/A
Ferrovial SE stock logo
FRRVY
Ferrovial
N/AN/AN/AN/AN/A
Rakuten Group, Inc. stock logo
RKUNY
Rakuten Group
N/AN/AN/AN/AN/A
Sino Biopharmaceutical Limited stock logo
SBMFF
Sino Biopharmaceutical
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Deutsche Wohnen SE stock logo
DWHHF
Deutsche Wohnen
N/AN/AN/A
Eurofins Scientific SE stock logo
ERFSF
Eurofins Scientific
N/AN/AN/A
Ferrovial SE stock logo
FRRVY
Ferrovial
N/AN/AN/A
Rakuten Group, Inc. stock logo
RKUNY
Rakuten Group
4.41
1.12
1.13
Sino Biopharmaceutical Limited stock logo
SBMFF
Sino Biopharmaceutical
N/AN/AN/A

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Deutsche Wohnen SE stock logo
DWHHF
Deutsche Wohnen
4,942400.30 millionN/ANot Optionable
Eurofins Scientific SE stock logo
ERFSF
Eurofins Scientific
55,631192.47 millionN/ANot Optionable
Ferrovial SE stock logo
FRRVY
Ferrovial
18,680727.44 millionN/ANot Optionable
Rakuten Group, Inc. stock logo
RKUNY
Rakuten Group
32,0792.14 billionN/ANot Optionable
Sino Biopharmaceutical Limited stock logo
SBMFF
Sino Biopharmaceutical
25,80618.81 billionN/ANot Optionable

ERFSF, SBMFF, DWHHF, FRRVY, and RKUNY Headlines

SourceHeadline
Sino Biopharmaceutical (OTCMKTS:SBMFF) Sets New 1-Year Low at $0.32Sino Biopharmaceutical (OTCMKTS:SBMFF) Sets New 1-Year Low at $0.32
americanbankingnews.com - April 21 at 5:38 AM
Sino Biopharm, Boehringer partner on oncology assets in ChinaSino Biopharm, Boehringer partner on oncology assets in China
bioworld.com - April 11 at 12:04 AM
Sino Biopharm and Boehringer Ingelheim enter into strategic collaborationSino Biopharm and Boehringer Ingelheim enter into strategic collaboration
chinadaily.com.cn - April 10 at 7:03 PM
Sino Biopharmaceutical to divest 67% stake in unit CP Qingdao for $253 mlnSino Biopharmaceutical to divest 67% stake in unit CP Qingdao for $253 mln
reuters.com - February 6 at 11:33 PM
Sino Biopharmaceutical to divest 67% stake in unit CP Qingdao for $253 millionSino Biopharmaceutical to divest 67% stake in unit CP Qingdao for $253 million
news.yahoo.com - February 6 at 11:33 PM
Sino Biopharmaceutical Ltd.Sino Biopharmaceutical Ltd.
wsj.com - January 30 at 9:44 PM
Jefferies Keeps Their Buy Rating on Sino Biopharmaceutical (SBMFF)Jefferies Keeps Their Buy Rating on Sino Biopharmaceutical (SBMFF)
markets.businessinsider.com - December 29 at 11:14 PM
Birminghams Ahmad Al Sino jailed for relatives wedding row murderBirmingham's Ahmad Al Sino jailed for relative's wedding row murder
bbc.co.uk - December 15 at 12:52 PM
Hong Kong Shares Turn Higher as Lower Oil Prices, Treasury Yields SupportHong Kong Shares Turn Higher as Lower Oil Prices, Treasury Yields Support
finance.yahoo.com - November 7 at 9:54 PM
Sino Biological opens Texas bioprocessing centerSino Biological opens Texas bioprocessing center
bioprocessintl.com - October 20 at 8:34 AM
Insights into Sino Biopharmaceutical Ltds Dividend PerformanceInsights into Sino Biopharmaceutical Ltd's Dividend Performance
finance.yahoo.com - October 4 at 9:05 AM
Sino Logistics Corporation PCL (SINO)Sino Logistics Corporation PCL (SINO)
uk.investing.com - September 29 at 6:54 PM
Sino Biopharmaceutical LtdSino Biopharmaceutical Ltd
jp.reuters.com - September 13 at 10:52 PM
Sino-Pak joint annual air exercise Shaheen-X begins in ChinaSino-Pak joint annual air exercise Shaheen-X begins in China
radio.gov.pk - September 13 at 10:52 PM
Patch-up plan fails; drawn-out Sino-Japan feud now expectedPatch-up plan fails; drawn-out Sino-Japan feud now expected
asahi.com - September 8 at 4:21 PM
Sino Biopharmaceutical Ltd ADR (SBHMY)Sino Biopharmaceutical Ltd ADR (SBHMY)
investing.com - July 17 at 12:55 AM
Sino Biopharm acquires obesity treatment from Gmax in $57M dealSino Biopharm acquires obesity treatment from Gmax in $57M deal
bioworld.com - June 16 at 10:05 AM
The Sino-Indian RivalryThe Sino-Indian Rivalry
cambridge.org - June 15 at 12:44 PM
Sino-ForestSino-Forest
forbes.com - May 30 at 9:14 PM
THAAD and the Sino-South Korean Strategic DilemmaTHAAD and the Sino-South Korean Strategic Dilemma
thediplomat.com - May 25 at 10:16 AM
Is a Sino-US War Inevitable?Is a Sino-US War Inevitable?
thediplomat.com - May 19 at 4:26 PM
Cantosino.com (SINO) MarketsCantosino.com (SINO) Markets
fxempire.com - March 26 at 7:17 PM
Sino Biopharmaceutical Limited (1177.HK)Sino Biopharmaceutical Limited (1177.HK)
finance.yahoo.com - March 12 at 7:29 AM
Sino Biopharm continues global growthSino Biopharm continues global growth
global.chinadaily.com.cn - March 9 at 7:12 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Deutsche Wohnen logo

Deutsche Wohnen

OTCMKTS:DWHHF
Deutsche Wohnen SE develops and manages residential properties in Germany. The company operates through Rental, Value-add, Recurring Sales, Development, and Care segment. The Rental segment offers value-enhancing management to residential real estate portfolio. The Value- add segment engages in the core business of letting. This segment also includes multimedia services and the supply of energy. The Recurring Sales segment includes sales of individual condominiums and single-family homes. The Development segment includes project development to create new living space. The care segment includes all activities related to the management of care facilities and the leasing of care properties. Deutsche Wohnen SE was founded in 1924 and is headquartered in Berlin, Germany. Deutsche Wohnen SE operates as a subsidiary of Vonovia SE.
Eurofins Scientific logo

Eurofins Scientific

OTCMKTS:ERFSF
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agroscience, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, healthcare and cosmetics, and food supplements; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include sustainability, expert services and regulatory, consumer research and sensory evaluation, audits, testing, certifications and approvals, inspections, and training courses for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, training and consulting; food irradiation and labelling, heavy metals, carbohydrates, radioactivity, nutritional analysis, microbiolody, and testing for persistent organic pollutants, veterinary drug residue, dioxins and organic contaminants, pesticides, mycotoxins, and vitamins, as well as analyses for genetic modifications. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and other services. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.
Ferrovial logo

Ferrovial

OTCMKTS:FRRVY
Ferrovial SE, together with its subsidiaries, develops transport infrastructure, mobility solutions, civil works, and buildings projects in Spain and internationally. The company designs and builds various public and private works; and develops, finances, and operates toll roads. Its construction activities include highways, tunnels, bridges, and airports; designs, constructs, operates and maintains potable water treatment plants, urban and industrial waste water treatment plants, and desalination plants. In addition, the company manufactures and markets asphalt and bitumen products; develops, operates, and manages airports; and promotes, constructs, and operates energy generation and transmission infrastructures. Further, it provides mobility services, include ZITY, an electric carsharing service application; invests in electric vehicle sector, including cars and associated charging infrastructures; and sells, rents, and maintains hydraulic equipment, jacks, and floating caisson equipment. The company was founded in 1952 and is based in Madrid, Spain.
Rakuten Group logo

Rakuten Group

OTCMKTS:RKUNY
Rakuten Group, Inc. provides services in e-commerce, fintech, digital content, and communications to various users in Japan and internationally. The company operates through three segments: Internet Services, FinTech, and Mobile. The Internet Services segment provides range of e-commerce sites, such as Rakuten Ichiba, an Internet shopping mall, online cash-back sites, travel booking sites, portal sites, and digital content sites. It also offers messaging services and sells advertising; and manages professional sport teams. The FinTech segment offers financial services over the internet related to banking and securities, credit cards, life insurance, general insurance, electronic payment business, crypto asset (virtual currency) spot transaction, etc. The Mobile segment provides communication services and technology, electricity supply, and digital content site services. The company was formerly known as Rakuten, Inc. and changed its name to Rakuten Group, Inc. in April 2021. Rakuten Group, Inc. was incorporated in 1997 and is headquartered in Setagaya, Japan.
Sino Biopharmaceutical logo

Sino Biopharmaceutical

OTCMKTS:SBMFF
Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company offers oncology medicines comprising Qingkeshu tablets, Focus V capsules, Annike injection, and Anyue capsules; liver disease medicines, including Tianqing ganmei injection and Runzhong dispersible tablets; and respiratory system medicines, such as Tianqing suchang suspension for inhalation and Tianyun for injection. It also provides surgery/analgesia medicines comprising Debaian cataplasms and Gaisanchun soft capsules; and cardio-cerebral vascular medicines, including Yilunping and Kaina tablets. In addition, the company is involved in the long term investments; and healthcare and hospital business. The company was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong.